image description

Tag: PhD

Project CHANGE Launches Pilot Programs in Atlanta, Nashville, and Philadelphia to Increase Diversity in Lupus Clinical Research

New York, NY. June 29. Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, today announced the launch of three pilot research initiatives for Project CHANGE, a community-driven approach to address systemic challenges contributing to the underrepresentation of people of color, particularly Black people, in lupus clinical trials. The sites selected to participate […] Read More

2017 Novel Research Grants – Meet the Awardees

July 28, 2017. The Lupus Research Alliance is delighted to announce the recipients of our 2017 Novel Research Grants. These ten grantees continue a commitment to bold and innovative research that aims to discover safe, effective treatments and a cure for lupus. Mridu Acharya, PhD Benaroya Research Institute at Virginia Mason Dr. Acharya is investigating the […] Read More

Saluting Women Shaping LRA’s Strategic Scientific Direction

March 8, 2022 In honor of Women’s History Month, the LRA is saluting the three exceptional women who serve on our Scientific Advisory Board. Each is a stand-out in lupus research discovery: Mary Collins, PhD, Instructor at Harvard Medical School;  Judith James, MD, PhD, Chair of the Arthritis and Clinical Immunology Program and Lou Kerr […] Read More

Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca’s anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE)

  First in New Class of Drugs in More than a Decade for SLE Targeting Type 1 Interferons NEW YORK, NY. August 2, 2021. The Lupus Research Alliance (LRA) is particularly excited about the U.S. Food and Drug Administration (FDA) approval of anifrolumab-fnia (Saphnelo™), a first-in-class type I interferon receptor antagonist indicated for adults with […] Read More

The LRA’s Forum for Discovery: Sharing the Latest News in Lupus Research

The Lupus Research Alliance (LRA) held our annual scientific conference, the Forum for Discovery, online in true 2020 fashion. More than 150 funded investigators, scientific advisors, and partners from the pharmaceutical and biotech industries logged on from their computers around the world to hear about new discoveries from LRA-funded researchers. LRA President Ken Farber emphasized […] Read More

LRA-Supported Study Discovers How Harmful Immune Cells Develop

August 17, 2020 In a new study published in the journal Immunity, Lupus Research Alliance-funded researcher Dr. Boris Reizis and his colleagues identified conditions under which immune cells called B cells begin to attack healthy genetic material (DNA). Dr. Reizis’ findings highlight the potential of drugs such as anifrolumab and BIIB-059 as potential treatments for […] Read More